About Bristol-Myers Squibb Company (BMY)

Company Description:

Bristol-Myers Squibb Company, a leading drug manufacturer, is primarily engaged in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of biopharmaceutical products worldwide. The company focuses on a range of therapeutic areas including oncology, cardiovascular, immunology, fibrosis, and others.

Founded in 1887 by William McLaren Bristol and John Ripley Myers, Bristol-Myers Squibb has grown to become a major player in the pharmaceutical industry. It is headquartered in New York, NY, United States.

Main Product(s):

Bristol-Myers Squibb is known for its wide range of prescription pharmaceuticals in several therapeutic areas, with a notable focus on cancer treatments, cardiovascular drugs, and immunology medications.

Short History of Bristol-Myers Squibb Company:

• 1887 – Founded as Bristol, Myers and Company.
• 1943 – The company merged with Squibb, forming Bristol-Myers Squibb.
• 1980s – Expanded into biotech with significant acquisitions.
• 2009 – BMS acquired Medarex, enhancing its focus on biologics.
• 2019 – The company completed its acquisition of Celgene, significantly expanding its oncology and immunology portfolio.
• 2020s – Continued focus on strategic collaborations and advancements in drug development, particularly in areas of unmet medical needs.